LRND Profile
The IQ U.S. Large Cap R&D Leaders ETF is designed to offer investors targeted exposure to U.S. large-cap companies that are prominent in research and development (R&D) activities. This ETF tracks an underlying index that focuses on companies with substantial investments in R&D, reflecting their commitment to innovation and technological advancement. The funds objective is to capitalize on the growth potential of firms leading in R&D spending, which often translates to competitive advantages and long-term market success.
To meet its investment goal, the fund invests at least 80% of its net assets, along with any borrowings for investment purposes, in securities that are part of the underlying index. This ensures that the ETF remains closely aligned with the performance of its benchmark. The underlying index specifically targets large-cap U.S. companies renowned for their significant R&D expenditures, positioning the fund to benefit from sectors where innovation drives growth and profitability.
The ETFs focus on high R&D spenders aims to capture the growth potential of companies that are investing heavily in developing new technologies and products. Companies with high R&D spending are often at the forefront of innovation, potentially leading to breakthroughs that can drive long-term revenue growth and market leadership. By concentrating on such firms, the fund seeks to offer investors exposure to the next generation of industry leaders and technological pioneers.
Managed by IndexIQ, a subsidiary of New York Life Investment Management, the ETF leverages the firm's expertise in creating and managing specialized investment strategies. IndexIQ is known for its innovative approach to ETF management, emphasizing unique and thematic investment opportunities. The IQ U.S. Large Cap R&D Leaders ETF is ideal for investors looking to gain exposure to large-cap companies with a strong emphasis on R&D, reflecting a strategy aimed at capturing the benefits of technological and scientific advancements.
|
